Chronic pain is a major public health challenge, affecting 100 million adults in the United States and resulting in over $600 billion annually in treatment costs and lost productivity. African-American (AA) adults are disproportionately affected by daily and chronic pain and report higher pain severity and greater pain-related disability across a variety of conditions. Compared to non-minorities with similar pain conditions, AA adults have poorer physical functioning, greater impairment at work and home, and lower quality of life. Daily bodily pain is common and often a precursor to chronic pain. Understanding the mechanisms that contribute to daily pain in AA adults is critical for prevention efforts targeting vulnerable adults before they develop debilitating and difficult to treat chronic pain conditions. Daily pain is more likely to become chronic in adults who have experienced adversity. Compared to non-minorities, AA adults report greater exposure to childhood trauma, family adversity, interpersonal violence, and racial discrimination. Thus, AA adults are impacted by disparities in risk factors for pain (adversity) and by chronic pain itself. Although the mechanisms linking adversity to daily pain in AA adults have not been clearly delineated, two promising pathways involve alterations of stress response systems (i.e., hypothalamic-pituitary-adrenal [HPA] axis) and pain sensitivity. The HPA axis plays an important role in stress-induced analgesia and may account, in part, for the relation between adversity and pain. Chronic and traumatic stressors are associated with diminished cortisol secretion. In turn, lower cortisol levels predict higher subsequent pain severity. Preliminary data suggest that prolonged HPA hypo-activity, indexed by hair cortisol concentration (HCC), is associated with greater pain intensity and pain-related disability. Despite theoretical models implicating HPA hypo-activity as a consequence of adversity and a risk factor for chronic pain, no studies have investigated HPA function as a mechanism linking adversity to daily pain in AA adults. Experimental pain responses correlate with pain intensity and predict risk for developing pain. Adversity is associated with altered evoked pain sensitivity. In turn, experimental pain responses predict daily and chronic pain. Although racial differences in experimental pain responses are well-established, no studies have tested altered pain sensitivity as a mechanism linking adversity to pain in AA adults. We will recruit 160 participants (~50% female), 18-45 years of age, without chronic pain, who self-identify as AA. Assessments at baseline, 6- and 12 months will determine exposure to adversity (self-report, geocoded crime report data), daily pain (intensity/disability), HCC (hair samples), and experimental pain facilitation and inhibition. Anticipated findings will highlight two novel mechanistic pathways linking cumulative adversity, which is more common in AA adults, to subsequent daily pain and disability. This proposal will also set the stage for secondary prevention efforts aimed at eliminating racial disparities in chronic pain by identifying HPA hypo- activity and evoked pain sensitivity as early risk markers for screening and potential targets for intervention.

Public Health Relevance

Chronic pain is a major public health challenge in the United States that disproportionately affects African- American adults. African-Americans experience greater exposure to adversities across the lifespan than non- minorities, which, in turn, is associated with elevated risk for the transition from daily to chronic pain. This prospective study will examine two novel mechanistic pathways linking cumulative adversity exposure to daily pain intensity and impairment in African-American adults - altered hypothalamic-pituitary-adrenal activity and experimental pain sensitivity.

Agency
National Institute of Health (NIH)
Institute
National Institute on Minority Health and Health Disparities (NIMHD)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54MD007586-33
Application #
9747115
Study Section
Special Emphasis Panel (ZMD1)
Project Start
Project End
Budget Start
2019-07-01
Budget End
2020-06-30
Support Year
33
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Meharry Medical College
Department
Type
DUNS #
041438185
City
Nashville
State
TN
Country
United States
Zip Code
37208
Warren Andersen, Shaneda; Blot, William J; Shu, Xiao-Ou et al. (2018) Associations Between Neighborhood Environment, Health Behaviors, and Mortality. Am J Prev Med 54:87-95
Bailey, Brooklynn; Morris, Matthew C (2018) Longitudinal Associations Among Negative Cognitions and Depressive and Posttraumatic Stress Symptoms in Women Recently Exposed to Stalking. J Interpers Violence :886260518807905
Zhang, Lin; Hu, Wei; Cho, Chi H et al. (2018) Reduced lysosomal clearance of autophagosomes promotes survival and colonization of Helicobacter pylori. J Pathol 244:432-444
Walker, Miriam Y; Pratap, Siddharth; Southerland, Janet H et al. (2018) Role of oral and gut microbiome in nitric oxide-mediated colon motility. Nitric Oxide 73:81-88
Xie, Yingqiu; Fan, Haiyan; Lu, Wenfu et al. (2018) Nuclear MET requires ARF and is inhibited by carbon nanodots through binding to phospho-tyrosine in prostate cancer. Oncogene :
Archibong, Anthony E; Rideout, Meredith L; Harris, Kenneth J et al. (2018) OXIDATIVE STRESS IN REPRODUCTIVE TOXICOLOGY. Curr Opin Toxicol 7:95-101
Smith Jr, Joseph T; Singha, Ujjal K; Misra, Smita et al. (2018) Divergent Small Tim Homologues Are Associated with TbTim17 and Critical for the Biogenesis of TbTim17 Protein Complexes in Trypanosoma brucei. mSphere 3:
McIntosh, Deneshia J; Walters, Treniqka S; Arinze, Ifeanyi J et al. (2018) Arkadia (RING Finger Protein 111) Mediates Sumoylation-Dependent Stabilization of Nrf2 Through K48-Linked Ubiquitination. Cell Physiol Biochem 46:418-430
Choi, Wonyoung; Kim, Jeongsik; Park, Jaeoh et al. (2018) YAP/TAZ Initiates Gastric Tumorigenesis via Upregulation of MYC. Cancer Res 78:3306-3320
Mimura, Kousaku; Teh, Jun Liang; Okayama, Hirokazu et al. (2018) PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer. Cancer Sci 109:43-53

Showing the most recent 10 out of 57 publications